A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...

This process can be repeated to improve monoclonal antibody affinity, seamlessly building in affinity maturation as part of the process. ADLib allows for constant diversification of antibodies (Fig.

Immunization of rodents leverages complex immune processes, notably repertoire selection and antibody affinity maturation that cannot be recreated completely in vitro. However, to avoid triggering ...

New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing ...

Germinal centers are high-speed evolution machines. Tiny clusters in the lymph nodes, germinal centers refine antibodies ...

antibody affinity maturation for therapeutic and diagnostic application; antibody chimerization for cloning and production of antibody domain; Eurofins preclinical services; hybrid service model ...

Antibody mAb 3A6 takes advantage of this little protein dance. It has such a strong affinity for its viral target that it can slip between the proteins, lift them up, and latch on its target.

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...

WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug ...

Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...

Oruka Therapeutics (ORKA) announced new preclinical data on ORKA-002, a novel extended half-life monoclonal antibody targeting IL-17A/F, from ...